no image available Dickens & Co. "A Prescription for Precision: Harnessing the Power of Bevacizumab in HER2-Negative Metastatic Breast Cancer" "Shedding Light on the Economic Benefits of Targeted Therapy in a Promising Case Study" Price: 30.00€